Literature DB >> 2915799

Prevalence of multiple sclerosis in Lanzarote (Canary Islands)

J R Garcia1, S Rodriguez, M Sosa Henriquez, E Batista, E Corujo, A Font de Mora Turon, D Hernandez Hernandez, P Betancor Leon.   

Abstract

In the island of Lanzarote of the Province of Las Palmas, which is part of the Spanish archipelago of the Canary Islands, the prevalence of multiple sclerosis is 15 per 100,000. The prevalence of MS in Lanzarote seems related more to ethnic conditions than to geography.

Entities:  

Mesh:

Year:  1989        PMID: 2915799     DOI: 10.1212/wnl.39.2.265

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain.

Authors:  E Bufill; R Blesa; I Galan; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

Review 2.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

3.  Cognitive status in patients with multiple sclerosis in Lanzarote.

Authors:  María Yaiza Pérez-Martín; Pablo Eguia-Del Río; Montserrat González-Platas; Alejandro Jiménez-Sosa
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-30       Impact factor: 2.570

4.  Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011-2015.

Authors:  Eva Blozik; Roland Rapold; Klaus Eichler; Oliver Reich
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-01       Impact factor: 2.570

5.  Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain.

Authors:  Silvia Pérez-Pérez; Pablo Eguia Del Rio; María Inmaculada Domínguez-Mozo; María Ángel García-Martínez; María Francisca Zapata-Ramos; Maria Jose Torrejon; Rafael Arroyo; Roberto Alvarez-Lafuente
Journal:  PeerJ       Date:  2019-12-18       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.